Group 1: Financial Performance - The company disclosed its mid-term forecast, indicating that the overall performance meets expectations with a net profit attributable to shareholders ranging from 0.63 to 0.78 billion, representing a year-on-year increase of 61.8% to 100.3%, with a median of 0.71 billion, up 81.1% [1] - For Q2, the net profit attributable to shareholders is projected to be between 0.36 and 0.51 billion, reflecting a year-on-year growth of 36.2% to 93.7%, with a median of 0.43 billion, an increase of 65% [1] - The company expects that excluding the impact of exchange rate fluctuations, net profit will fall within the upper range, driven by sustained high growth of its proprietary brands [1] Group 2: New Brand Launch - The company launched a new health supplement brand, VitaOcean, which features differentiated ingredients and a mature operational model, indicating strong certainty for success [2] - The core ingredient of VitaOcean is deep-sea ruby oil from the Arctic, targeting women with its main product priced at ¥498 for 60 capsules, claiming benefits such as antioxidant, anti-inflammatory, and enhanced metabolism with double the absorption rate of concentrated fish oil [2] - The company aims to leverage the operational model accumulated from its existing brand, Fichui, combined with the differentiated cost positioning of ruby oil to create a high-certainty success path for VitaOcean [2] Group 3: Growth Strategy - The company focuses on differentiated positioning in high-end fragrance home cleaning and oral beauty products, exploring new consumer scenarios and driving growth through dual channels and multiple explosive products [2] - VitaOcean is expected to become a significant growth driver in the second half of 2025, with a clear focus on core female demographics and in-depth exploration of niche demand scenarios [2] - The company is anticipated to continue expanding its brand matrix in the health sector, showcasing its forward-looking vision and clear growth trajectory [2]
若羽臣(003010):H1预告符合预期 关注绽家斐萃高增数据兑现&新品牌增量弹性